L'effetto della privazione del sonno e del sonno di recupero sulla memoria emotiva e sulla reattività affettiva
To further understand the impact of acute sleep deprivation and recovery sleep on the processing of emotional information the investigators will address and attempt to answer three questions, (i) how both undisturbed sleep and sleep deprivation affect the processing and retrieval of emotional information, (ii) what neural and psychophysiological mechanisms are associated with these behavioral effects, and (iii) to explore the ability of recovery sleep to reverse the effects of sleep deprivation. Together, these studies will provide a greater breadth and depth of knowledge concerning sleep's role in emotion processing and regulation. Given the growing societal tendency to view sleep as unproductive-foregoing it to lengthen work days and increase social opportunities- such knowledge would be of practical importance for understanding the role of sleep in healthy emotional functioning, particular for individuals experiencing periods of increased stress and emotional distress (e.g., new parents, hospital staff, or combat troops).
Panoramica dello studio
Stato
Stato
Condizioni
Condizioni
Intervento / Trattamento
Intervento / Trattamento
Descrizione dettagliata
Goal 1: How does sleep deprivation impact emotion perception and memory processing? The investigators are interested in how an acute loss of sleep impairs our ability to properly perceive, consolidate, and retrieve emotional information. There has been research on the effect of sleep deprivation on broad areas of cognition, such as attention, working memory, and reasoning ability, but the impact of sleep loss on emotional processing and regulation remains largely unexplored. The investigators aim to characterize how sleep deprivation compared to undisturbed sleep affects the ability to accurately perceive emotion, how it alters the intensity with which emotions are perceived, and the effect that these changes have on the subsequent consolidation and memory retrieval for emotional compared to neutral information.
Goal 2: How are these changes reflected in the neural signal and with psychophysiological measures? The investigators will utilize functional magnetic resonance imaging (fMRI) and measures of autonomic reactivity (heart rate and skin conductance) to characterize the neural and psychophysiological mechanisms underlying these behavioral changes following sleep deprivation compared to a normal night of sleep. This will allow us to pinpoint the brain regions involved in changes following sleep deprivation, and associate these changes with effects on downstream physiological responses.
Goal 3: Can a nap after sleep deprivation restore normal processing of emotional memory and rescue the neural and autonomic markers of sleep deprivation? The investigators are interested in determining if a brief period of recovery sleep is enough to combat the behavioral, neural, and autonomic effects of acute sleep loss, thus a portion of the sleep-deprived participants will be given a 2-hour nap opportunity to quantify its restorative effects. Such information would form the foundation for future research extending and translating these findings into effective sleep-based interventions for healthy and clinical populations alike.
Tipo di studio
Tipo di studio
Iscrizione (Stimato)
Iscrizione
Fase
Fase
- Non applicabile
Contatti e Sedi
Luoghi di studio
-
-
Massachusetts
-
Boston, Massachusetts, Stati Uniti, 02215
- Tony Cunningham
-
-
Criteri di partecipazione
Criteri di ammissibilità
Criteri di ammissibilità
Età idonea allo studio
Accetta volontari sani
Sessi ammissibili allo studio
Descrizione
Inclusion Criteria:
- willing and able to follow the protocol
- willing and able to meet inclusion criteria for fMRI scanning
- willing to refrain from alcohol and recreational drugs for the duration of the protocol
- normal or corrected to normal vision is required
Exclusion Criteria:
- self-reported sleep disturbances
- left-handedness or ambidexterity
- a history of mental illness or neurological disorder
- the use of any drugs that could affect either sleep or cognitive functioning (e.g., sleeping pills or antidepressants)
Piano di studio
Come è strutturato lo studio?
Dettagli di progettazione
- Scopo principale: Scienza basilare
- Assegnazione: Randomizzato
- Modello interventistico: Assegnazione parallela
- Mascheramento: Nessuno (etichetta aperta)
Numero di armi
Armi e interventi
Gruppo di partecipanti / ArmGruppo di partecipanti / Arm |
Intervento / TrattamentoIntervento / Trattamento |
|---|---|
|
Nessun intervento: Overnight sleep
Subjects are permitted a night of polysomnograph-recorded sleep before participating in training and testing sessions the next day |
|
|
Comparatore attivo: Sleep deprivation
Subjects sleep deprived before participating in training and testing sessions the next day |
Subjects are sleep deprived for an entire night |
|
Sperimentale: Daytime Nap
Subjects are trained and then retested after a daytime nap |
Subjects are sleep deprived for an entire night After a night of sleep deprivation, participants will be given a 2 hour nap opportunity |
Cosa sta misurando lo studio?
Misure di risultato primarie
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Morphed Face Accuracy and Intensity
Lasso di tempo: 1-24 hours
|
Participants are asked to identify and rate emotional intensity of ambiguous emotional faces (happy, sad, angry) that have been morphed with neutral faces. Scores for each emotional domain will be calculated as (i) accuracy score (number of faces correctly identified over total faces seen), and (ii) average emotional intensity rating. Task will be completed at baseline, post-sleep/sleep deprivation, and post-nap/no nap, and within-subject comparisons will determine how interventions impact emotional perception. |
1-24 hours
|
|
Emotional Memory Tradeoff Memory Score
Lasso di tempo: 12-24 hours
|
Following sleep or sleep deprivation, participants will complete emotional memory tradeoff recognition task at two time points, separated by a nap or wakefulness. Corrected hit rate will be calculated for negative and neutral scene components as the percentage of correctly identified "old" objects/backgrounds minus percentage of false alarms ("new" pictures marked as "old") |
12-24 hours
|
|
Psychomotor vigilance task lapse rate
Lasso di tempo: 1-24 hours
|
The absolute number of trials in a 5-min test period on which the participant fails to responds with 500ms is calculated as the lapse rate. |
1-24 hours
|
Misure di risultato secondarie
Misure di risultato secondarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
fMRI measured neural reactivity (blood oxygen-level dependent signal)
Lasso di tempo: 12-24 hours
|
Following sleep or sleep deprivation, regions of interest include amygdala reactivity and connectivity between the amygdala and the ventromedial prefrontal cortex (vmPFC) in response to negative and neutral stimuli. |
12-24 hours
|
|
Heart Rate Reactivity (Beats per minute)
Lasso di tempo: 12-24 hours
|
The change in heart rate beats per minute in response to negative and neutral stimuli after sleep or sleep deprivation. |
12-24 hours
|
|
Skin Conductance Reactivity (micro Siemens)
Lasso di tempo: 12-24 hours
|
The change in electrodermal activity in response to negative and neutral stimuli after sleep or sleep deprivation. |
12-24 hours
|
Collaboratori e investigatori
Sponsor
Sponsor
Collaboratori
Collaboratori
Investigatori
Investigatori
- Investigatore principale: Tony Cunningham, PhD, Beth Israel Deaconess Medical Center
Studiare le date dei record
Studia le date principali
Inizio studio (Effettivo)
Inizio studio
Completamento primario (Effettivo)
Completamento primario
Completamento dello studio (Stimato)
Completamento dello studio
Date di iscrizione allo studio
Primo inviato
Primo inviato
Primo inviato che soddisfa i criteri di controllo qualità
Primo inviato che soddisfa i criteri di controllo qualità
Primo Inserito (Effettivo)
Primo Inserito
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Effettivo)
Ultimo aggiornamento pubblicato
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo verificato
Ultimo verificato
Maggiori informazioni
Termini relativi a questo studio
Parole chiave
Termini MeSH pertinenti aggiuntivi
Altri numeri di identificazione dello studio
Altri numeri di identificazione dello studio
- TC-1
Informazioni su farmaci e dispositivi, documenti di studio
Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti
Studia un dispositivo regolamentato dalla FDA degli Stati Uniti
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .